LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 80.88 | 17.25 | 2576 | 5826 | 0.4422 | 0.8148 | MN20160310_N02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 80.88 | 17.25 | 2608 | 5826 | 0.4476 | 0.8175 | MN20160310_N02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 82.85 | 17.25 | 2105 | 5861 | 0.3591 | 0.7707 | MN20160310_N02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 82.85 | 17.25 | 2138 | 5861 | 0.3647 | 0.7739 | MN20160310_N02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 82.85 | 17.25 | 2623 | 5861 | 0.4475 | 0.8176 | MN20160310_N02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 82.85 | 17.25 | 2658 | 5861 | 0.4535 | 0.8205 | MN20160310_N02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 84.82 | 17.25 | 2179 | 5924 | 0.3678 | 0.7761 | MN20160310_N02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 84.82 | 17.25 | 2222 | 5924 | 0.3751 | 0.7802 | MN20160310_N02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 84.82 | 17.25 | 2712 | 5924 | 0.4578 | 0.8228 | MN20160310_N02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 84.82 | 17.25 | 2751 | 5924 | 0.4644 | 0.8259 | MN20160310_N02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 86.79 | 17.25 | 2222 | 6008 | 0.3698 | 0.7777 | MN20160310_N02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 86.79 | 17.25 | 2272 | 6008 | 0.3781 | 0.7824 | MN20160310_N02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 86.79 | 17.25 | 2808 | 6008 | 0.4674 | 0.8277 | MN20160310_N02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 86.79 | 17.25 | 2844 | 6008 | 0.4734 | 0.8305 | MN20160310_N02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 88.76 | 17.25 | 2344 | 6047 | 0.3876 | 0.7879 | MN20160310_N02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 88.76 | 17.25 | 2385 | 6047 | 0.3944 | 0.7915 | MN20160310_N02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 88.76 | 17.25 | 2899 | 6047 | 0.4793 | 0.8334 | MN20160310_N02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 88.76 | 17.25 | 2933 | 6047 | 0.4850 | 0.8359 | MN20160310_N02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 90.74 | 17.25 | 2347 | 6109 | 0.3842 | 0.7863 | MN20160310_N02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 90.74 | 17.25 | 2395 | 6109 | 0.3920 | 0.7906 | MN20160310_N02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 90.74 | 17.25 | 2995 | 6109 | 0.4902 | 0.8385 | MN20160310_N02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 90.74 | 17.25 | 3038 | 6109 | 0.4973 | 0.8416 | MN20160310_N02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 92.71 | 17.25 | 2437 | 6184 | 0.3941 | 0.7921 | MN20160310_N02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 92.71 | 17.25 | 2492 | 6184 | 0.4030 | 0.7969 | MN20160310_N02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 92.71 | 17.25 | 3090 | 6184 | 0.4997 | 0.8430 | MN20160310_N02 | I05 |